Price Chart

Profile

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
URL https://www.repligen.com
Investor Relations URL https://www.repligen.com/company/Investors/investors-overview
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Mid Cap/Growth
Next Earnings Release May. 02, 2024 (est.)
Last Earnings Release Feb. 21, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
URL https://www.repligen.com
Investor Relations URL https://www.repligen.com/company/Investors/investors-overview
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Mid Cap/Growth
Next Earnings Release May. 02, 2024 (est.)
Last Earnings Release Feb. 21, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A